U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07594977) titled 'Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers' on May 12.
Brief Summary: This open-label study will evaluate the effect of food on the bioavailability of a single dose of 4-MUST, tablets, 128 mg. Additionally, the study will assess the pharmacokinetics, safety, and tolerability of 4-MUST, tablets, 128 mg following both single and multiple oral dose administration.
Study Start Date: Jan. 26
Study Type: INTERVENTIONAL
Condition:
Chronic Cholecystitis
Biliary Dyskinesia
Intervention:
DRUG: 4-MUST
128 mg tablets containing trimebutine 4-methyl...